12/05/2025
👶🏼💉There has been a historic vote by the CDC’s vaccine advisory group (ACIP) that may change how we approach hepatitis B protection for newborns in the United States.
For over 30 years, all babies have routinely received the hepatitis B vaccine shortly after birth. This universal strategy has played a major role in reducing serious liver infections caused by the hepatitis B virus.
What’s changing?
ACIP has voted to end the universal birth-dose recommendation and narrow its guidance:
➡️ Babies born to mothers who test positive for hepatitis B should still receive the vaccine at birth.
➡️ For mothers who are negative or whose status is unknown, the new guidance encourages a conversation with your healthcare provider to decide what’s best.
This change is not yet final—it still needs approval from the CDC’s acting director.
At Bloom Pediatrics, your baby’s health and safety always come first. If you’re expecting or planning your newborn care, I’m here to walk with you through these updates, answer questions, and help you make informed decisions that feel right for your family.
If you’re pregnant or planning to become pregnant, now is a great time to make sure your hepatitis B screening is up to date. ✔️
Feel free to reach out with questions or schedule a prenatal consult. 💛